IP Rights and Technology Transfer

IP Rights and Technology Transfer

Stephen Susalka, Chief Executive Officer of AUTM, discusses how university technology transfer powers the innovation economy – creating jobs, saving and enhancing lives, and improving productivity – the Bayh-Dole Act, which has enabled tremendous progress in innovation, and the importance of strong and predictable intellectual property protections.

Weak IP Terminology and the Need to Restore Patent Infringement Injunctions

Kristen Jakobsen Osenga, Associate Dean for Academic Affairs at the University of Richmond School of Law, discusses patent eligibility and preliminary injunctions in patent litigation, how strong intellectual property protections drive innovation, and some of the terminology (i.e., “evergreening” and “patent thickets”) often used by advocates for weaker intellectual property protections.

IP Protections Essential to the Free Market and Startup Economy

Mark Schultz, the Goodyear Tire and Rubber Company Chair in Intellectual Property and Director of the Intellectual Property and Technology Law Program at the University of Akron School of Law, discusses how strong intellectual property (IP) protections are essential to the free market and modern economy, and the need to return to a more effective and predictable IP system in the U.S.

Strong IP Protections Are Critical to Ensuring Continued U.S. Innovation Leadership

David Kappos, Co-Chair of the Intellectual Property Practice at Cravath, Swaine & Moore LLP, and former Undersecretary of Commerce and Director of the U.S. Patent and Trademark Office, discusses how strong intellectual property (IP) protections are essential for the U.S. to continue to lead the world in innovation, the importance of IP protections to attract capital necessary to innovate, and the need for Congress to act to fix issues dealing with injunctive relief for patent infringement, patent eligibility, and the Patent Trial and Appeal Board (PTAB).

Foreign Price Controls Undermine IP Rights and Impede Innovation

Sally Pipes, President, CEO and Thomas W. Smith Fellow in Healthcare Policy at the Pacific Research Institute, discusses how “Most Favored Nation” pricing schemes, which seek to import foreign price controls on prescription drugs, would harm innovation, undermine intellectual property rights and threaten America’s pharmaceutical supremacy, a better way to address foreign freeloading, the success of the Bayh-Dole Act, and more.